The risk of cancer (an unrestrained growth of abnorma cells) is dramatically increased with the use of drugs like Proscar, according to Jan-Ake Gustafsson, M.D. and professor of medicine at Karolinska Institute in Stockholm, Sweden. Dr. Gustafsson concluded his extensive study on the effects of common prostate medicines on the body, reporting his initial findings in 2001. Recent, more comprehensive studies proved that certain pharmaceuticals dramatically increased the risk of cancer by inhibiting the release of testosterone in the prostate and thereby limiting its essential by-product, beta-receptor, which carry out the critical role of controlling the growth of the prostate cells. These findings, once again, expose the hazardous nature of some pharmaceuticals in their purported quest to heal disease.